A Survey of Didemnin Depsipeptide Production in Tistrella
Marine Drugs · 2023
DOI: 10.3390/md21020056 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, 2023. Verfasst von Robert J Stankey und 4 weiteren Autor:innen. Beteiligte Einrichtung: Terra Bioworks Inc., Middleton, WI 53562, USA. Hauptthemen laut MEDLINE: Antineoplastic Agents, Depsipeptides. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Xenobe Research Institute, Terra Bioworks.
Abstract (Originalsprache)
As one of the first families of marine natural products to undergo clinical trials, the didemnin depsipeptides have played a significant role in inspiring the discovery of marine drugs. Originally developed as anticancer therapeutics, the recent re-evaluation of these compounds including synthetically derived dehydrodidemnin B or Aplidine, has led to their advancement towards antiviral applications. While conventionally associated with production in colonial tunicates of the family Didemnidae, recent studies have identified their biosynthetic gene clusters from the marine–derived bacteria Tistrella mobilis. While these studies confirm the production of didemnin X/Y, the low titer and general lack of understanding of their biosynthesis in Tistrella currently prevents the development of effective microbial or synthetic biological approaches for their production. To this end, we conducted a survey of known species of Tistrella and report on their ability to produce the didemnin depsipeptides. These data were used to develop conditions to produce didemnin B at titers over 15 mg/L.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Terra Bioworks Inc., Middleton, WI 53562, USA.
- Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, 9500 Gilman Drive, San Diego, CA 92093-0657, USA.
- Department of Chemistry and Biochemistry, University of California, San Diego, CA 92093-0358, USA.
- Xenobe Research Institute, P.O. Box 3052, San Diego, CA 92163-1052, USA.
ORCID-Profile: Robert J Stankey, Brendan M Duggan, David A Mead, James J La Clair
Förderung
- Xenobe Research Institute
- Terra Bioworks
Zitieren
APA
Stankey, R. J., Johnson, D., Duggan, B. M., Mead, D. A., & La Clair, J. J. (2023). A Survey of Didemnin Depsipeptide Production in Tistrella. Marine Drugs. https://doi.org/10.3390/md21020056
Vancouver
Stankey RJ, Johnson D, Duggan BM, Mead DA, La Clair JJ. A Survey of Didemnin Depsipeptide Production in Tistrella. Marine Drugs. 2023. doi:10.3390/md21020056
BibTeX
@article{Stankey2023,
author = {Stankey, Robert J and Johnson, Don and Duggan, Brendan M and Mead, David A and La Clair, James J},
title = {A Survey of Didemnin Depsipeptide Production in Tistrella},
journal = {Marine Drugs},
year = {2023},
doi = {10.3390/md21020056}
}
EUVIMED